China Expected To Become World's Second-Largest OTC Market Next Year
This article was originally published in PharmAsia News
Next year, China is expected to become second only to the United States in terms of the value of the market for over-the-counter drugs, according to one expert
You may also be interested in...
Sanofi Diversifies In China With $70 Million To Expand Production Capability For Animal Health Division Merial
SHANGHAI - Sanofi-Aventis' animal health division Merial Animal Health broke ground on a $70 million expansion of its Nanchang manufacturing site, six months after Sanofi CEO Chris Viehbacher said his company aims to diversify in China
Chief medical officer Samit Hirawat outlines R&D successes – though there have been some setbacks since it bought Celgene for $74bn last year – and the company’s commitment to clinical trial diversity.
Letter from department’s general counsel responds to request from the company for a pre-enforcement advisory opinion. Despite the letter, Lilly maintains its ‘limited distribution program is fully consistent with applicable laws and regulations.’